Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PanaBIOS is an active digital public health and health-travel technology organization that emerged during the COVID-19 pandemic to provide cross-border health verification, disease surveillance, testing workflow digitization, and related public health infrastructure. The platform supports electronic test-result certificates, vaccination and travel health documentation, contact tracing, venue screening, and analytics for disease contagion monitoring. It has been described as African Union-backed and is used in connection with initiatives such as Trusted Travel and Global Haven. Rather than developing therapeutics, PanaBIOS operates as a healthcare IT and digital health platform focused on public health operations, interoperability, and pandemic-era mobility solutions. Its offerings appear to be commercially deployed across multiple countries and laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PanaBIOS.